Kavar Capital Partners Group, LLC Amgen Inc Transaction History
Kavar Capital Partners Group, LLC
- $599 Million
- Q1 2025
A detailed history of Kavar Capital Partners Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 1,056 shares of AMGN stock, worth $296,567. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,056
Previous 1,050
0.57%
Holding current value
$296,567
Previous $273,000
20.15%
% of portfolio
0.05%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,231Shares Held
422MCall Options Held
7.05MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$14.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.27 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.09 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.71 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $150B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...